| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A recombinant 2019-nCov Nucleocapsid Protein expressed in E.coli was used as the immunogen for the recombinant rabbit-human chimeric SARS-CoV-2 Nucleocapsid Protein antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target |
Overview
Human Chimeric SARS-CoV-2 Nucleocapsid Protein Antibody (2019-nCov) is an antibody targeting PROTEIN, raised in Rabbit for protein detection and localization studies where these specifications are required.
Key elements and design rationale
- Target: PROTEIN.
- Antibody identity: Recombinant Rabbit Monoclonal; Clone RMH03; Chimeric (this antibody is recognized only by an anti-Human IgG secondary antibody).
- Conjugate/label: Unconjugated (affects detection chemistry and multiplex compatibility).
- Format: Purified.
- Species reactivity: SARS-CoV.
- Listed applications: Sandwich ELISA assay as a detect antibody paired with clone RM420 (refer to on-page specifications for application-specific guidance).
Biological background
This antibody is a Rabbit-Human Chimeric antibody made by fusion of the antigen binding region (variable domains of the heavy and light chains, VH and VL) of a rabbit anti-NP(2019-nCov) monoclonal antibody with the constant domain of Human IgG1. It reacts to Nucleocapsid Protein of SARS-CoV-2 (2019-nCov). No cross-reactivity to common SARS coronaviruses observed. It can be used as the detect antibody in a Sandwich ELISA assay with clone RM420 monoclonal antibody. This antibody is recognized only by an anti-Human IgG secondary antibody.
Research relevance and current trends
- Comparative expression profiling across cell types, tissues, or perturbations (e.g., drug treatment, genetic editing, or differentiation).
- Subcellular localization and trafficking studies, including co-localization with pathway markers in microscopy-based assays.
- Integration of protein-level measurements with transcriptomics or proteomics to relate abundance to regulation and phenotype.
Common research applications
- ELISA: researchers commonly compare relative signal levels across conditions and use appropriate negative/positive controls for interpretation.
Interpretation should account for antibody-dependent factors such as epitope accessibility, isoforms, and sample preparation differences across workflows.
Notes for experimental interpretation
- Isoforms and PTMs: many targets have multiple isoforms and post-translational modifications that can shift apparent signal or localization; interpret bands/signals accordingly.
- Epitope context: binding can depend on protein conformation and sample processing; region information in the title/immunogen can help anticipate what may be detected.
- Species differences: predicted or validated reactivity may vary by ortholog sequence and sample context; confirm in your model system.
- Control concepts: include negative controls (no-primary/isotype), and where possible genetic controls (KO/KD) or independent antibodies to strengthen conclusions.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
